The CMS, China lifesciences team would like to introduce the 2nd edition of its legal guide to China, a 130 page guide to the lifesciences industry in China fully updated.

To successfully establish a presence in China or distribute their products, lifesciences companies need to carefully take into account all the specificities of the Chinese legal, regulatory and tax environment.

In this highly regulated sector, this guide gives to lifesciences companies an insightful overview of the main legal, regulatory and tax issues that they may encounter when investing in China, from matters surrounding the establishment or acquisition of a business, registration, promotion, import and distribution of drugs and medical devices, daily operation, compliance to product liability and intellectual property protection or general matters such as application for mandatory licences to specific issues in relation to M&A transactions and technology transfer.

If you would like to receive a complimentary copy of our Lifesciences A Legal guide to China (2nd edition) then please email and provide your postal address.

To download the cover page and table of content of the guide, please click here .

This article was written for Law-Now, CMS Cameron McKenna's free online information service. To register for Law-Now, please go to

Law-Now information is for general purposes and guidance only. The information and opinions expressed in all Law-Now articles are not necessarily comprehensive and do not purport to give professional or legal advice. All Law-Now information relates to circumstances prevailing at the date of its original publication and may not have been updated to reflect subsequent developments.

The original publication date for this article was 09/06/2010.